Raphael Erez — SEC insider filings
SEC reporting owner CIK 1668046. 19 insider filings on record with FilingPulse; latest filed 2026-09-28.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2020-10-20 to 2026-09-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 8 legs across 5 filings — 34,455 shares, $22,780 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): 8 legs across 5 filings — 108,923 shares, $2,008,010 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 41,279 shares @ $18.66 ($770,464) in DarioHealth Corp., filed 2021-11-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| DarioHealth Corp. (DRIO) | Chief Executive Officer, Director | 19 | 8 legs · 34,455 sh · $22,780 | 8 legs · 108,923 sh · $2,008,010 | 13 |
Insider filings — Raphael Erez
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-28 | 4 | DarioHealth Corp. (DRIO) | Conversion (C): 579 @ $19.10 · Grant/award (A): 297,000 @ $0 · Conversion (C): 30 (derivative) @ $1,000 | EDGAR |
| 2025-09-15 | 4 | DarioHealth Corp. (DRIO) | Grant/award (A): 60,000 @ $0 | EDGAR |
| 2024-08-28 | 4 | DarioHealth Corp. (DRIO) | Purchase (P): 5,000 @ $0.88 | EDGAR |
| 2024-08-23 | 4 | DarioHealth Corp. (DRIO) | Purchase (P): 5,000 @ $0.93 · Purchase (P): 5,000 @ $0.95 | EDGAR |
| 2024-08-20 | 4 | DarioHealth Corp. (DRIO) | Purchase (P): 2,000 @ $0.89 · Purchase (P): 3,000 @ $0.90 · Purchase (P): 5,000 @ $0.90 | EDGAR |
| 2024-03-08 | 4 | DarioHealth Corp. (DRIO) | Grant/award (A): 800,000 @ $0 | EDGAR |
| 2023-05-08 | 4 | DarioHealth Corp. (DRIO) | Purchase (P): 30 (derivative) @ $1,000 | EDGAR |
| 2023-01-18 | 4 | DarioHealth Corp. (DRIO) | Sale (S): 1,200 @ $6.21 | EDGAR |
| 2022-05-20 | 4 | DarioHealth Corp. (DRIO) | Grant/award (A): 275,000 @ $0 | EDGAR |
| 2021-11-09 | 4 | DarioHealth Corp. (DRIO) | Sale (S): 200 @ $19.05 · Sale (S): 800 @ $19.08 | EDGAR |
| 2021-11-05 | 4 | DarioHealth Corp. (DRIO) | Sale (S): 30,483 @ $18.96 · Sale (S): 7,857 @ $18.49 | EDGAR |
| 2021-11-03 | 4 | DarioHealth Corp. (DRIO) | Sale (S): 25,804 @ $18.01 · Sale (S): 41,279 @ $18.66 | EDGAR |
| 2021-10-12 | 4 | DarioHealth Corp. (DRIO) | Grant/award (A): 695 @ $0 | EDGAR |
| 2021-07-20 | 4 | DarioHealth Corp. (DRIO) | Grant/award (A): 688 @ $0 | EDGAR |
| 2021-07-19 | 4 | DarioHealth Corp. (DRIO) | Sale (S): 1,300 @ $17.63 | EDGAR |
| 2021-05-20 | 4/A | DarioHealth Corp. (DRIO) | Grant/award (A): 2,268 @ $0 · Grant/award (A): 413,158 @ $0 | EDGAR |
| 2021-05-05 | 4 | DarioHealth Corp. (DRIO) | Grant/award (A): 673 @ $0 | EDGAR |
| 2021-01-21 | 4 | DarioHealth Corp. (DRIO) | Purchase (P): 2,268 @ $0 · Grant/award (A): 413,158 @ $0 | EDGAR |
| 2020-10-20 | 4 | DarioHealth Corp. (DRIO) | Purchase (P): 7,187 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-19 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1668046 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs